Lipocube SVF introduced to the UK market

24 Jun 2021

Medical device supplier Advantech Surgical will be introducing the Lipocube SVF stem cell isolation product to the UK market.

According to the company, the product allows for fat tissue to be disaggregated and incubated by mixing it with the Lipocube buffer solution, enhancing the separation of regenerative cells from the fat tissue. The emulsion is processed in the Lipocube Cell-Drive and the stromal vascular fraction (SVF) is concentrated in a patented trap with a specific cell coating and geometry. This SVF is then applied to the patient.

The product is easy to use and quick with a small amount of adipose tissue passing through the Lipocube SVF device.

Managing director of Advantech Surgical Ben Sharples says, “We are very excited to add Lipocube SVF to our already strong offering in regenerative medicine. We can now offer options to surgeons and patients across all budgets and to suit all surgical requirements. This new addition makes our companies, leaders in regenerative medicine.” 


Log-in to post a comment